Table 3. Summary of outcomes Pt. .... | American Society of Hematology

Table 3.

Summary of outcomes

Pt.	Baseline mRSS	Baseline DLCO	Survival, mo	Status	Last disease evaluation
Pt.	Baseline mRSS	Baseline DLCO	Survival, mo	Status	Months after HDIT	mRSS	DLCO, %	mHAQ-DI
1	47	76	44.8	Alive, Cy for PD (lung disease)	36	10	55	1.0
2	29	48	39.6	Alive, FK-506 for PD (lung disease)	36	12	42	0
3	30	57	36.1	Alive, no therapy for SSc	36	8	69	0
4	32	47	^3-150	Died on + 58 pulmonary toxicity	—	—	—	—
5	30	46	31.9	Alive, no therapy for SSc	24	20	42	0.375
6	35	67	24.8	Alive, no therapy for SSc	24	3	60	0.125
7	50	52	^3-150	Died on + 79 pulmonary toxicity	—	—	—	—
8	39	62	22.9	Alive, no therapy for SSc	12	26	57	0.2
9	14	45	17.1	Alive, no therapy for SSc	12	1	52	0
10	3	66	^3-150	Died on + 64 EBV-PTLD	—	—	—	—
11	40	57	14.7	Alive, no therapy for SSc	12	24	60	0.75
12	27	57	14.5	Alive, no therapy for SSc	12	18	41	0.25
13	24	47	12.8	Alive, no therapy for SSc	12	6	54	0.5
14	18	66	12.8	Alive, no therapy for SSc	12	10	66	0
15	31	84	12.8	Alive, prednisone 8 mg/d	12	21	60	1.25
16	36	56	^3-150	Died + 123 of PD (renal failure)	—	—	—	—
17	43	47	10.8	Alive, no therapy for SSc	6	46	28	2.25 (3)
18	19	69	9.6	Alive, no therapy for SSc	3	15	49	2.125
19	32	72	7.5	Alive, no therapy for SSc	3	7	52	0.450

Pt.	Baseline mRSS	Baseline DLCO	Survival, mo	Status	Last disease evaluation
Pt.	Baseline mRSS	Baseline DLCO	Survival, mo	Status	Months after HDIT	mRSS	DLCO, %	mHAQ-DI
1	47	76	44.8	Alive, Cy for PD (lung disease)	36	10	55	1.0
2	29	48	39.6	Alive, FK-506 for PD (lung disease)	36	12	42	0
3	30	57	36.1	Alive, no therapy for SSc	36	8	69	0
4	32	47	^3-150	Died on + 58 pulmonary toxicity	—	—	—	—
5	30	46	31.9	Alive, no therapy for SSc	24	20	42	0.375
6	35	67	24.8	Alive, no therapy for SSc	24	3	60	0.125
7	50	52	^3-150	Died on + 79 pulmonary toxicity	—	—	—	—
8	39	62	22.9	Alive, no therapy for SSc	12	26	57	0.2
9	14	45	17.1	Alive, no therapy for SSc	12	1	52	0
10	3	66	^3-150	Died on + 64 EBV-PTLD	—	—	—	—
11	40	57	14.7	Alive, no therapy for SSc	12	24	60	0.75
12	27	57	14.5	Alive, no therapy for SSc	12	18	41	0.25
13	24	47	12.8	Alive, no therapy for SSc	12	6	54	0.5
14	18	66	12.8	Alive, no therapy for SSc	12	10	66	0
15	31	84	12.8	Alive, prednisone 8 mg/d	12	21	60	1.25
16	36	56	^3-150	Died + 123 of PD (renal failure)	—	—	—	—
17	43	47	10.8	Alive, no therapy for SSc	6	46	28	2.25 (3)
18	19	69	9.6	Alive, no therapy for SSc	3	15	49	2.125
19	32	72	7.5	Alive, no therapy for SSc	3	7	52	0.450

PD indicates progressive disease; mRSS, modified Rodnan skin score, mHAQ-DI, modified Health Assessment Questionnaire Disability Index.

Patient died.